AnaptysBio Overview
AnaptysBio Target Price
See AnaptysBio's analyst price targets ($77) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$56.02
Average Target Price
$77.20
37.8% upside
37.8% upside5 analysts in the last 4 months
High: $90 | Low: $60
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-15 | Leerink Partners | $90 | 60.7% upside |  |
| 2026-05-13 | UBS | $76 | 35.7% upside | |
| 2026-05-13 | Barclays | $75 | 33.9% upside | |
| 2026-04-28 | Leerink Partners | $85 | 51.7% upside | |
| 2026-04-21 | UBS | $60 | 7.1% upside | |
| 2026-03-06 | Truist FinancialJohn Lee | $50 |  10.7% downside | |
| 2026-03-05 | Stifel NicolausAlex Thompson | $85 | 51.7% upside | |
| 2026-03-04 | H.C. WainwrightEmily Bodnar | $66 | 17.8% upside | |
| 2026-01-07 | UBSMichael Yee | $70 | 25% upside | |
| 2025-12-18 | Guggenheim | $140 | 149.9% upside | |
| 2025-12-17 | BarclaysEtzer Darout | $55 | 1.8% downside | |
| 2025-12-11 | Stifel Nicolaus | $56 | 0% upside | |
| 2025-11-11 | Barclays | $70 | 25% upside | |
| 2025-11-10 | WedbushDavid Nierengarten | $50 | 10.7% downside | |
| 2025-11-10 | Truist FinancialJoon Lee | $36 | 35.7% downside | |
| 2025-10-29 | Stifel Nicolaus | $80 | 42.8% upside | |
| 2025-10-15 | WedbushDavid Nierengarten | $70 | 25% upside | |
| 2025-10-13 | Barclays | $78 | 39.2% upside | |
| 2025-09-30 | H.C. Wainwright | $59 | 5.3% upside | |
| 2025-05-06 | GuggenheimYatin Suneja | $54 | 3.6% downside | |
| 2025-03-03 | Guggenheim | $52 | 7.2% downside | |
| 2025-02-04 | Wolfe ResearchAndy Chen | $25 | 55.4% downside | |
| 2024-12-11 | H.C. WainwrightEmily Bodnar | $19 | 66.1% downside | |
| 2024-11-06 | H.C. WainwrightEmily Bodnar | $52 | 7.2% downside | |
| 2024-11-06 | Leerink PartnersDavid Risinger | $45 | 19.7% downside | |
| 2024-10-21 | GuggenheimYatin Suneja | $90 | 60.7% upside | |
| 2024-10-15 | Piper SandlerYasmeen Rahimi | $80 | 42.8% upside | |
| 2024-10-03 | New StreetDavid Risinger | $35 | 37.5% downside | |
| 2024-08-15 | Truist FinancialJoon Lee | $30 | 46.4% downside | |
| 2024-04-16 | Leerink PartnersDavid Risinger | $47 | 16.1% downside | |
| 2022-11-18 | J.P. Morgan | $32 | 42.9% downside | |